Meet the Expert Sessions
|
|
Friday, April 5, 2019 | 07:30-08:30
|
Lafora
|
| Integrating Cladribine Tablets into clinical practice Prof. Mark Freedman and Dr. Celia Oreja-Guevara |
Supported by Merck
 |
|
Friday, April 5, 2019 | 07:30-08:30
|
Lorente de Nó
|
| Targeting B cells in MS Dr. Ron Milo |
Supported by Roche
 |
|
Friday, April 5, 2019 | 13:15-14:15
|
Lafora
|
| Spotlight on the antiepileptic drug eslicarbazepine acetate: sharing experience from clinical practice Dr. Vicente Villanueva |
Supported by Bial/Eisai
  |
|
Friday, April 5, 2019 | 13:15-14:15
|
Rio Hortega
|
| AMBAR (Alzheimer´s Management By Albumin Replacement) Trial Results: Clinical and Biomarker Update Laura Núñez, BSc and Dr. Javier Olazarán |
Supported by Grifols
 |
|
Friday, April 5, 2019 | 13:15-14:15
|
Lorente de Nó
|
| Update on Clinical Use of Pimavanserin and PD Psychosis Chair Dr. Stuart Isaacson, Dr. Rajesh Pahwa, Dr. Fatta Nahab, Dr. Daniel Kremens |
Supported by Acadia
 |
|
Saturday, April 6, 2019 | 12:25-13:25
|
Lafora
|
| Neurogenic Orthostatic Hypotension: I. Clinical Diagnosis of NOH; II. Distinguishing NOH from OFF Symptoms; III. Currrent Approach to NOH Treatment Chair Dr. Stuart Isaacson, Dr. Fiona Gupta, Dr. Laxman Bahroo |
Supported by Lundbeck
 |
|
Saturday, April 6, 2019 | 12:25-13:25
|
Rio Hortega
|
| Emerging perspectives on the use of “on-demand” therapies to treat OFF episodes Dr. Mark Lew, Dr. Daniel Kremens, Prof. Per Odin, |
Supported by USWM/Britannia
  |
|
Saturday, April 6, 2019 | 18:00-19:00
|
Lorente de Nó
|
| OFF Episodes in PD: GI Dysmotility and Emerging Non-Oral, On-Demand Therapies Chair Dr. Stuart Isaacson, Dr. Laxman Bahroo, Dr. Fiona Gupta, Dr. Mark Lew |
Supported by Acorda
 |
